Side-by-side financials for CADL and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CADL | BNTX |
|---|---|---|
| Market cap | - | $22.64 B |
| US-listed rank | - | #570 |
| Revenue (latest FY) | $125.00K | - |
| Net income (latest FY) | -$38.18M | - |
| Net margin | -30545.6% | - |
| SEC filings | 382 | 548 |
Full pages: Candel Therapeutics, Inc. and BioNTech SE, or browse the full rankings.